All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @themyamethod on TikTok · 28s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @themyamethod's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I don't wanna be a big back no more
  2. 0:04I'm not greedy, I just eat a lot
  3. 0:06It's summer time, if my back's still big I know
  4. 0:10No one else is still round
  5. 0:12I don't wanna be a big back no more
  6. 0:14I'm not greedy, I just eat a lot
  7. 0:16It's summer time, if my back's still big I know
  8. 0:20I'm round the round
  9. 0:22Hey yo, I'm still not greedy but you gotta feed me fettuccine
  10. 0:25Rockly with the cheese, I need cheese on top of the cheese
  11. 0:27Chicken now

GLP-1 high-protein meal prep: what the science says about eating on semaglutide

Mya| VA Hairstylist

TikTok creator

53.4K viewsWatch on TikTok

Quick answer

The creator is using humor to document her GLP-1-assisted weight loss journey, referencing persistent cravings for calorie-dense foods like fettuccine and cheese alongside active behavioral strategies like protein prioritization and portion control. This reflects a clinically recognized pattern where GLP-1 receptor agonists reduce physical hunger but do not fully suppress hedonic food cravings, requiring continued behavioral modification. No clinical claims are made in the video, and no medical guidance should be inferred from the content.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 high-protein meal prep: what the science says about eating on semaglutide, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 high-protein meal prep: what the science says about eating on semaglutide" from Mya| VA Hairstylist. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is using humor to document her GLP-1-assisted weight loss journey, referencing persistent cravings for calorie-dense foods like fettuccine and cheese alongside active behavioral strategies like protein prioritization and portion control.

The reason this review is not generic is the source wording and the canonical claim label "glp1 i only cut up about 4 5 of those chicken tenderloins btw glp." In this clip, the useful excerpt is: "I don't wanna be a big back no more I'm not greedy, I just eat a lot It's summer time, if my back's still big I know No one else is still round I don't wanna be a big back no more I'm not greedy, I just eat a lot It's summer time, if my..." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Hedonic eating, or eating driven by pleasure rather than hunger, uses separate neural pathways that are only partially affected by GLP-1 medications (Blundell et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is using humor to document her GLP-1-assisted weight loss journey, referencing persistent cravings for calorie-dense foods like fettuccine and cheese alongside active behavioral strategies like protein prioritization and portion control.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is using humor to document her GLP-1-assisted weight loss journey, referencing persistent cravings for calorie-dense foods like fettuccine and cheese alongside active behavioral strategies like protein prioritization and portion control. This reflects a clinically recognized pattern where GLP-1 receptor agonists reduce physical hunger but do not fully suppress hedonic food cravings, requiring continued behavioral modification. No clinical claims are made in the video, and no medical guidance should be inferred from the content.
  • GLP-1 receptor agonists reduce physical hunger primarily through slowed gastric emptying and increased satiety signaling, not by eliminating food cravings entirely (Grill and Hayes, 2022, Cell Metabolism).
  • Hedonic eating, or eating driven by pleasure rather than hunger, uses separate neural pathways that are only partially affected by GLP-1 medications (Blundell et al., 2017, Diabetes, Obesity and Metabolism).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • GLP-1 receptor agonists reduce physical hunger primarily through slowed gastric emptying and increased satiety signaling, not by eliminating food cravings entirely (Grill and Hayes, 2022, Cell Metabolism).
  • Hedonic eating, or eating driven by pleasure rather than hunger, uses separate neural pathways that are only partially affected by GLP-1 medications (Blundell et al., 2017, Diabetes, Obesity and Metabolism).
  • The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide participants achieved up to 22.5% body weight reduction, but all participants also followed a reduced-calorie diet and increased physical activity.
  • Protein prioritization during caloric restriction is evidence-backed: higher protein intake supports satiety and limits lean muscle loss, per Leidy et al. (2015, American Journal of Clinical Nutrition).
  • Compounded GLP-1 medications are not FDA-approved and are not equivalent to brand-name drugs like Wegovy or Zepbound. Any GLP-1 therapy should be prescribed and monitored by a licensed healthcare provider.
  • Pre-portioning food before eating, the behavior this creator jokes about with her chicken tenderloins, is a validated behavioral strategy for reducing overall caloric intake independent of medication use.
  • No single TikTok video, including this one, should substitute for individualized medical advice on GLP-1 therapy, dosing, or dietary planning.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @themyamethod actually say?

Honestly? Not much, medically speaking. This video is a comedic lip-sync to a parody song about not wanting to be a "big back" anymore, punctuated by a self-aware caption admitting she only cut up "about 4/5" of her chicken tenderloins. The creator references eating fettuccine with cheese "on top of the cheese" in the audio, which she's using ironically to contrast with her GLP-1 weight loss journey. There are no explicit health claims here. What she is communicating, through humor, is the very real psychological tension between food cravings and trying to eat in a calorie deficit while on a GLP-1 medication. That tension is actually clinically documented, and it's worth unpacking.

Does the science back this up?

The cravings conflict she's joking about? Completely real, and more nuanced than most people think. GLP-1 receptor agonists like semaglutide and tirzepatide do suppress appetite, but they don't erase food preference or the psychological pull toward high-fat, high-calorie foods. Research from Blundell et al. (2017, Diabetes, Obesity and Metabolism) found that while GLP-1 agonists reduce overall energy intake, hedonic eating, meaning eating for pleasure rather than hunger, remains a separate neurological pathway that isn't fully suppressed by these drugs. A 2023 paper by Chao et al. in Obesity Reviews specifically noted that food cravings, particularly for savory and high-fat foods like, say, fettuccine with extra cheese, can persist even as physical hunger decreases. So the joke about still wanting cheese on top of cheese isn't just relatable content. It's a real pharmacological reality that clinicians should probably be talking about more openly.

What did they get wrong (or right)?

There are no false medical claims to correct here, which is refreshing compared to a lot of GLP-1 content on TikTok. Credit where it's due: by framing this as comedy and self-deprecation rather than advice, @themyamethod avoids the most common pitfalls in this space, like overstating results, dismissing side effects, or implying the medication does all the work. The implicit message, that she's still actively managing portion sizes and eating high-protein meals while on GLP-1 therapy, is actually consistent with clinical guidance. The SCALE trial (Davies et al., 2015, The Lancet) and SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) both showed that lifestyle modification alongside GLP-1 therapy produces significantly better outcomes than medication alone. Cutting up "4/5" of the chicken before stopping is, in a weird way, portion control in action. She's not wrong.

What should you actually know?

If you're on a GLP-1 medication and still experiencing strong food cravings, especially for specific comfort foods, that is not a sign the medication isn't working. Appetite suppression and craving reduction are distinct mechanisms. GLP-1 agonists primarily work by slowing gastric emptying, increasing satiety signals, and modulating insulin response. They are not a complete override of the brain's reward system around food. A 2022 study by Grill and Hayes in Cell Metabolism confirmed that dopaminergic food reward pathways remain partially active even under GLP-1 receptor activation. This means behavioral strategies, like pre-portioning food before you start eating, which is essentially what this creator describes, still matter. Protein prioritization, which the hashtag "highproteinmeals" references, is also evidence-backed. Higher protein intake supports satiety and preserves lean muscle mass during caloric restriction, per Leidy et al. (2015, American Journal of Clinical Nutrition).

The bottom line

This video is comedy, not a medical tutorial, and it should be consumed as such. But embedded in the joke is something clinically honest: GLP-1 medications help, they are not magic, and the mental negotiation around food doesn't just disappear. Anyone telling you otherwise is selling something. If you are considering GLP-1 therapy, talk to a licensed provider who can assess your full health picture. Compounded versions of these medications are not equivalent to FDA-approved brand-name drugs, and dose decisions should never come from social media, including this one.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Mya| VA Hairstylist · TikTok creator

53.4K views on this video

I only cut up about 4/5 of those chicken tenderloins btw 😂 #glp1 #weightloss #easymealideas #highproteinmeals #caloriedeficit #unbiggingmyback 😂

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about glp-1 receptor agonists reduce physical hunger primarily through slowed gastric?

GLP-1 receptor agonists reduce physical hunger primarily through slowed gastric emptying and increased satiety signaling, not by eliminating food cravings entirely (Grill and Hayes, 2022, Cell Metabolism).

What does the video say about hedonic eating,?

Hedonic eating, or eating driven by pleasure rather than hunger, uses separate neural pathways that are only partially affected by GLP-1 medications (Blundell et al., 2017, Diabetes, Obesity and Metabolism).

What does the video say about the surmount-1 trial (jastreboff et al., 2022, nejm) showed tirzepatide?

The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide participants achieved up to 22.5% body weight reduction, but all participants also followed a reduced-calorie diet and increased physical activity.

What does the video say about protein prioritization during caloric restriction?

Protein prioritization during caloric restriction is evidence-backed: higher protein intake supports satiety and limits lean muscle loss, per Leidy et al. (2015, American Journal of Clinical Nutrition).

What does the video say about compounded glp-1 medications?

Compounded GLP-1 medications are not FDA-approved and are not equivalent to brand-name drugs like Wegovy or Zepbound. Any GLP-1 therapy should be prescribed and monitored by a licensed healthcare provider.

What does the video say about pre-portioning food before eating, the behavior this creator jokes about?

Pre-portioning food before eating, the behavior this creator jokes about with her chicken tenderloins, is a validated behavioral strategy for reducing overall caloric intake independent of medication use.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Mya| VA Hairstylist, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.